Biotechnology is central to U.S. national strategy, representing a crucial battleground in the competition with China. The National Security Commission on Emerging Biotechnology’s report urges
Author: Jude Baxter
Jude Baxter is an accomplished author and thought leader specializing in new technologies and financial technology (fintech). With a Master’s degree in Digital Innovation from the renowned Stanford University, Jude combines academic rigor with a passion for exploring the transformative impacts of technology on global finance. His insights are informed by over a decade of experience at Quantum Technologies, where he played a pivotal role in developing groundbreaking fintech solutions. Jude's writing is characterized by a keen analytical approach and a commitment to making complex subjects accessible to a broad audience. Through his work, he aims to empower readers to navigate the rapidly evolving landscape of technology and finance.
Will Biotechnology Define America’s Future? A New Commission Warns Congress of the Stakes
The National Security Commission on Emerging Biotechnology warns U.S. leadership in biotechnology is at risk, particularly in competition with China. Biotechnology’s rapid advancements impact national
Financial Maestro Joins Nuclera Amid Global Expansion Ambitions
Nuclera, a UK-based life sciences innovator, is expanding its global influence with new leadership. William J. Kullback, renowned for his financial expertise, joins Nuclera to
Is White Biotechnology the Future of Sustainable Energy? Stunning Predictions Inside
Unraveling the Surge in White Biotechnology The global white biotechnology market is witnessing a remarkable transformation, poised to expand from $425.76 billion in 2024 to